Soon after the Zika epidemic broke out in Brazil, Mayana Zatz - an acclaimed geneticist who, for the preceding four decades had been tracking rare genetic disorders that destroy muscles - received a surprise phone call from the scientific director of a research foundation in São Paulo. Carlos de Brito Cruz told her Brazil was in a crisis and asked if she could contribute in any way. It was 2015, and scientists were trying to establish a link between the Zika virus - usually a mild condition that can cause flu-like symptoms - and a [...]
Conteúdo na íntegra disponível para assinantes do veículo.